HERPUD1 and cancer: Given that targeting UPR transcription factors is being explored in cancer treatment [18, 79] but affects multiple proteins, our results highlight CK2-mediated phosphorylation-dependent regulation of HERPUD1 as a promising therapeutic strategy against TNBC, a cancer that urgently requires more effective treatments.